Work Productivity in Hyperventilation Syndrome

NCT03292523 | Completed

• 2 other identifiers: 2016_682017-A01542-51
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

Hyperventilation syndrome is associated with impaired quality of life. The aim of the study is to assess the relationship between work productivity, including absenteeism and presenteeism, and the severity of hyperventilation syndrome

Conditions

Hyperventilation Syndrome

Keywords

Hyperventilation syndrome; Work productivity; Absenteeism; Presenteeism

Outcome Measures

Primary Outcomes (1)

• Association between the WPAI score and the Nijmegen score

  At the time of diagnosis (Baseline)

Secondary Outcomes (4)

• Association between the WPAI score and dyspnea scales

  At the time of diagnosis (Baseline)

• Association between the WPAI score and quality of life scores

  At the time of diagnosis (Baseline)

• Association between the WPAI score and PaCO2

  At the time of diagnosis (Baseline)

• Association between the WPAI score and the Cognitive Failure Questionnaire score

  At the time of diagnosis (Baseline)

Study Arms (1)

Hyperventilation syndrome

Other: questionnaire

Interventions

questionnaire OTHER

Work Productivity and Activity Impairment (WPAI) Multidimensional Dyspnea Profile (MDP) Baseline Dyspnea Index (BDI), MOS-SF36, Hospital Anxiety Depression (HAD) Cognitive Failure Questionnaire (CFQ).

Hyperventilation syndrome

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

patients with confirmed hyperventilation syndrome, virgin of any treatment.

You may qualify if:

• Holders of employment contracts for at least 8 days
• Diagnosis of hyperventilation syndrome confirmed by:
• Compatible symptoms and at least two symptoms reproduced by the hyperventilation challenge test: Nijmegen's score\> 23 ; Demonstration of alveolar hyperventilation ( Either on rest blood and / or at rest (PaCO2 at rest \<36 mmHg and D (A-a) O2 normal; Either during the HV test (increased recovery time of the basic PETCO2 after voluntary hyperventilation (greater than 5 minutes)

You may not qualify if:

• Existence of another chronic pulmonary disease (asthma, bronchial dilation, COPD, diffuse interstitial pneumonia, neuromuscular pathology ...) or cardiac (rhythm disorder, ischemic heart disease ...) which can participate in dyspnea
• Psychiatric illness / psychotropic treatment
• Pregnancy
• Patient already included in a clinical research protocol involving new therapeutics may not be included in this protocol
• Specific physiotherapy or previous training

Sponsors & Collaborators

• University Hospital, Lille: lead

Study Sites (1)

Hôpital Calmette,CHU

Lille, France

Location

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Cécile Chenivesse, MD

  University Hospital, Lille

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 21, 2017
• First Posted: September 25, 2017
• Study Start: February 6, 2018
• Primary Completion: February 23, 2021
• Study Completion: February 23, 2021
• Last Updated: April 29, 2022

Record last verified: 2022-04

Locations

FR (1)